article

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

Psychiatry Research · 1979 · Vol. 1(3) · pp. 249–254

Glenn C. Davis✉(University of Tennessee at Knoxville)Adrian Williams(National Institute of Neurological Disorders and Stroke)Sanford P. Markey(National Institute of Mental Health)Michael H. EbertEric D. CaineCheryl M. Reichert(National Cancer Institute)Irwin J. Kopin

View via DOI Publisher page

Glycogen Storage Diseases and Myoclonus Neurological disorders and treatments Epilepsy research and treatmentParkinsonismAnesthesiaMedicinePharmacologyInternal medicine

MeSH terms

AdultBromocriptineCarbidopaChronic DiseaseHumansLevodopaLocus CoeruleusMaleMeperidineOpioid-Related DisordersParkinson Disease, SecondarySubstantia Nigra

Citations

1,361

FWCI

0.54

field-weighted impact

References

Percentile

69%

vs. same field & year

Citations per year

Cited by

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey